Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 58
15
Diseases
22
Unique genes
0.345
Avg. similarity score
Alpha-actinopathy
Most-connected disease (8 links)
Disease
Searched: Congenital myopathy 2a, typical, autosomal dominant
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Congenital myopathy 2a, typical, autosomal dominant
Alpha-actinopathy
Congenital nemaline myopathy
Myopathy, actin, congenital, with excess of thin myofilaments
Nemaline myopathy 3, autosomal dominant or recessive
Zebra body myopathy
Rigid spine muscular dystrophy
Congenital myopathy 2b, severe infantile, autosomal recessive
Congenital myopathy 2c, severe infantile, autosomal dominant
Nemaline myopathy
Nemaline myopathy 10
Nemaline myopathy 8
Nemaline myopathy 9
Congenital myopathy 3 with rigid spine
Nemaline myopathy 7
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Alpha-actinopathy | 8 | 8 | 1 |
| Congenital nemaline myopathy | 8 | 8 | 5 |
| Myopathy, actin, congenital, with excess of thin myofilaments | 8 | 8 | 1 |
| Nemaline myopathy 3, autosomal dominant or recessive | 8 | 8 | 1 |
| Zebra body myopathy | 8 | 8 | 1 |
| Congenital myopathy 2a, typical, autosomal dominant | 7 | 7 | 1 |
| Rigid spine muscular dystrophy | 6 | 6 | 3 |
| Congenital myopathy 2b, severe infantile, autosomal recessive | 5 | 5 | 1 |
| Congenital myopathy 2c, severe infantile, autosomal dominant | 5 | 5 | 1 |
| Nemaline myopathy | 5 | 5 | 20 |
| Nemaline myopathy 10 | 2 | 2 | 1 |
| Nemaline myopathy 8 | 2 | 2 | 1 |
| Nemaline myopathy 9 | 2 | 2 | 1 |
| Congenital myopathy 3 with rigid spine | 1 | 1 | 1 |
| Nemaline myopathy 7 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ACTA1 | 10 / 15 | Alpha-actinopathy, Congenital myopathy 2a, typical, autosomal dominant, Congenital myopathy 2b, severe infantile, autosomal recessive, Congenital myopathy 2c, severe infantile, autosomal dominant and 6 more |
| KLHL40 | 3 / 15 | Congenital nemaline myopathy, Nemaline myopathy, Nemaline myopathy 8 |
| KLHL41 | 3 / 15 | Congenital nemaline myopathy, Nemaline myopathy, Nemaline myopathy 9 |
| LMOD3 | 3 / 15 | Congenital nemaline myopathy, Nemaline myopathy, Nemaline myopathy 10 |
| CFL2 | 2 / 15 | Nemaline myopathy, Nemaline myopathy 7 |
| NEB | 2 / 15 | Congenital nemaline myopathy, Nemaline myopathy |
| SELENON | 2 / 15 | Congenital myopathy 3 with rigid spine, Rigid spine muscular dystrophy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cytoskeleton in muscle cells | KEGG | 11 / 232 | 25.9× | 6.46e-14 | 1.57e-11 ✓ sig. |
| Striated Muscle Contraction | Reactome | 7 / 36 | 106× | 1.93e-13 | 4.23e-11 ✓ sig. |
| Motor proteins | KEGG | 7 / 194 | 19.7× | 3.58e-8 | 2.28e-6 ✓ sig. |
| Cholesterol biosynthesis | Reactome | 2 / 21 | 52.0× | 6.59e-4 | 8.26e-3 ✓ sig. |
| Terpenoid backbone biosynthesis | KEGG | 2 / 23 | 47.5× | 7.92e-4 | 9.48e-3 ✓ sig. |
| Smooth Muscle Contraction | Reactome | 2 / 34 | 32.1× | 1.73e-3 | 1.72e-2 ✓ sig. |
| Activation of gene expression by SREBF (SREBP) | Reactome | 2 / 42 | 26.0× | 2.64e-3 | 2.33e-2 ✓ sig. |
| Cardiac muscle contraction | KEGG | 2 / 87 | 12.5× | 1.09e-2 | 6.01e-2 |
| Hypertrophic cardiomyopathy | KEGG | 2 / 99 | 11.0× | 1.40e-2 | 6.96e-2 |
| Dilated cardiomyopathy | KEGG | 2 / 105 | 10.4× | 1.56e-2 | 7.44e-2 |
| PPARA activates gene expression | Reactome | 2 / 115 | 9.5× | 1.85e-2 | 8.21e-2 |
| Cell-extracellular matrix interactions | Reactome | 1 / 12 | 45.5× | 2.18e-2 | 9.00e-2 |
| Adrenergic signaling in cardiomyocytes | KEGG | 2 / 154 | 7.1× | 3.19e-2 | 1.12e-1 |
| Unblocking of NMDA receptors, glutamate binding and activation | Reactome | 1 / 22 | 24.8× | 3.96e-2 | 1.27e-1 |
| Butanoate metabolism | KEGG | 1 / 27 | 20.2× | 4.83e-2 | 1.42e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| sarcomere organization | GO:0045214 | 6 / 43 | 119× | 7.49e-12 | 2.92e-9 ✓ sig. |
| striated muscle contraction | GO:0006941 | 4 / 24 | 142× | 1.51e-8 | 2.52e-6 ✓ sig. |
| skeletal muscle fiber development | GO:0048741 | 4 / 31 | 110× | 4.44e-8 | 6.42e-6 ✓ sig. |
| actin filament organization | GO:0007015 | 5 / 152 | 27.9× | 7.85e-7 | 7.03e-5 ✓ sig. |
| regulation of ATP-dependent activity | GO:0043462 | 2 / 2 | 849× | 1.32e-6 | 1.08e-4 ✓ sig. |
| muscle contraction | GO:0006936 | 4 / 85 | 40.0× | 2.74e-6 | 1.95e-4 ✓ sig. |
| skeletal muscle contraction | GO:0003009 | 3 / 32 | 79.6× | 6.87e-6 | 4.06e-4 ✓ sig. |
| skeletal muscle thin filament assembly | GO:0030240 | 2 / 6 | 283× | 1.98e-5 | 9.16e-4 ✓ sig. |
| regulation of striated muscle contraction | GO:0006942 | 2 / 8 | 212× | 3.69e-5 | 1.47e-3 ✓ sig. |
| transition between fast and slow fiber | GO:0014883 | 2 / 9 | 189× | 4.74e-5 | 1.78e-3 ✓ sig. |
| cellular response to caffeine | GO:0071313 | 2 / 11 | 154× | 7.23e-5 | 2.43e-3 ✓ sig. |
| isoprenoid biosynthetic process | GO:0008299 | 2 / 13 | 131× | 1.02e-4 | 3.15e-3 ✓ sig. |
| myofibril assembly | GO:0030239 | 2 / 15 | 113× | 1.38e-4 | 3.88e-3 ✓ sig. |
| regulation of muscle contraction | GO:0006937 | 2 / 16 | 106× | 1.57e-4 | 4.29e-3 ✓ sig. |
| sterol biosynthetic process | GO:0016126 | 2 / 31 | 54.8× | 6.03e-4 | 1.08e-2 ✓ sig. |